In a small proportion of melanomas, loss of HLA class I expression is caused by mutation of the B2M gene [60,63]; however, epigenetic mechanisms or translational dysregulation are much more frequent mechanisms of HLA class I loss in cancers [64,65]. This evidence concerns the gene B2M and melanoma.